Skip to content

Clinical trials

Phase 3 Dry Eye Syndromes trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dry Eye Syndromes Phase: Phase 3 Country / region: United States Clear all

77 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20042
20062
20102
20112
20123
20131
20145
20152
20169
20184
20197
20205
20218
20229
20234
20246
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70
Unknown status4
Terminated2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan8
Aldeyra Therapeutics, Inc.5
Mimetogen Pharmaceuticals USA, Inc.5
Alcon Research4
Bausch & Lomb Incorporated4
Shire4
Aerie Pharmaceuticals3
HanAll BioPharma Co., Ltd.3
Kala Pharmaceuticals, Inc.3
Sirion Therapeutics, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dry Eye Syndromes77
Keratoconjunctivitis Sicca13
Hyperemia2
Keratoconjunctivitis2
Pain2
Sjogren's Syndrome2
Arthritis, Rheumatoid1
Autoimmune Diseases1
Conjunctival Diseases1
Corneal Diseases1

Trials

Showing 1 to 25 of 77. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.